// App-Quantinova.ai

3352 : Calcium/calmodulin-dependent protein kinase II alpha (CaMK2A) regulates the tumor initiating cell phenotype through SOX2 expression and modulates treatment response to anti-cancer drugs in lung adenocarcinoma

Researchers

Presenter

  • Maria P. Wong

Principal Investigators

  • Jing Liu

  • Zhi-Jie Xiao

  • Si-Qi Wang

  • Vicky Pc Tin

Medical Centers

  • The Chinese University of Hong Kong, Hong Kong, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Thyroid Cancer

  • Solid malignancies

Biomarkers

  • Activated leucocyte cell adhesion molecule

  • NANOG

  • Aryl hydrocarbon receptor nuclear translocator-like protein 1

  • Epidermal growth factor receptor

  • SRY-Box 2

  • Trimethylation of lysine 27 on histone H3

Drug/Treatment

  • gefitinib

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A